drugset / Trial / NCT00002386

Effect of Indinavir Plus Two Other Anti-HIV Drugs on Blood Clotting in HIV-Positive Males With Hemophilia

NCT00002386 ↗

Phase 4 Completed 55 enrolled Merck Sharp & Dohme LLC
Treatment

Summary

The purpose of this study is to see if indinavir plus two other anti-HIV drugs affect blood clotting in HIV-positive patients with hemophilia.

Timeline

Start
—
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Didanosine Small molecule — —
Subject INDINAVIR ANHYDROUS Other / unclassified — —
Subject Lamivudine Other / unclassified — —
Subject Stavudine Other / unclassified — —
Subject Zalcitabine Small molecule — —
Subject Zidovudine Small molecule — —